Morgan Stanley Maintains Equal-Weight on Hologic, Raises Price Target to $76

Morgan Stanley analyst David Lewis maintains Hologic (NASDAQ:HOLX) with a Equal-Weight and raises the price target from $75 to $76.

Morgan Stanley analyst David Lewis maintains Hologic (NASDAQ:HOLX) with a Equal-Weight and raises the price target from $75 to $76.

Total
0
Shares
Related Posts